Received Aug 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 42Y93 | — |
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 42Y93 | — |
Kinrix was administered at 2 months old and another dose at 4 months old instead of Pediarix.; Kinrix was administered at 2 months old and another dose at 4 months old instead of Pediarix; Kinrix was administered at 2 months old and another dose at 4 months old instead of Pediarix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 11-month-old female patient who received DTPa-IPV (Kinrix) (batch number 42Y93, expiry date 05-JUN-2026) for prophylaxis. Co-suspect products included DTPa-IPV (Kinrix) (batch number 42Y93, expiry date 05-JUN-2026) for prophylaxis and DTPa-HBV-IPV (Pediarix) for prophylaxis. On an unknown date, the patient received Kinrix, Kinrix. On an unknown date, an unknown time after receiving Kinrix and Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Kinrix was administered at 2 months old and another dose at 4 months old instead of Pediarix.), inappropriate schedule of vaccine administered (Verbatim: Kinrix was administered at 2 months old and another dose at 4 months old instead of Pediarix) and wrong vaccine administered (Verbatim: Kinrix was administered at 2 months old and another dose at 4 months old instead of Pediarix). The outcome of the inappropriate age at vaccine administration, inappropriate schedule of vaccine administered and wrong vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 28-JUL-2025 LPN called to report that they administered a dose of Kinrix to a female patient at 2 and 4 months old instead of Pediarix, 2nd line MIS confirmed that Kinrix was the 1st and 2nd dose of DTaP and IPV which led to inappropriate age at vaccine administration, inappropriate schedule of vaccine administered and wrong vaccine administered.